Results
1 -
10 of
39Delineation of the interactions between the chemotherapeutic agent eribulin mesylate (E7389) and human CYP3A4, Cancer Chemotherapy and Pharmacology Story of Eribulin Mesylate: Development of the Longest Drug Synthesis, Synthesis of Heterocycles in Contemporary Medicinal Chemistry Marine Sponge Derived Eribulin in Preclinical and Clinical Studies for Cancer, Handbook of Anticancer Drugs from Marine Origin Marine-Derived Fungal Metabolites, Springer Handbook of Marine Biotechnology The Deep Oceans as a Source for New Treatments for Cancer, Chembiomolecular Science Pharmacokinetics of eribulin mesylate in cancer patients with normal and impaired renal function, Cancer Chemotherapy and Pharmacology Pharmacokinetics of eribulin mesylate in patients with solid tumors and hepatic impairment, Cancer Chemotherapy and Pharmacology Phase 1, open-label, dose-escalation study of sorafenib in combination with eribulin in patients with advanced, metastatic, or refractory solid tumors, Cancer Chemotherapy and Pharmacology Health-related quality of life in patients with locally advanced or metastatic breast cancer treated with eribulin mesylate or capecitabine in an open-label randomized phase 3 trial, Breast Cancer Research and Treatment